Bright Minds Biosciences (TSE:DRUG) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Bright Minds Biosciences is set to present groundbreaking data on its novel drug BMB-101 at the American Epilepsy Society’s 2024 Annual Meeting. The company focuses on innovative treatments for drug-resistant epilepsy and other CNS disorders, showcasing the potential of BMB-101 in advancing epilepsy management.
For further insights into TSE:DRUG stock, check out TipRanks’ Stock Analysis page.
